Pharma firm commits to improve maternal health in low-income countries

US pharmaceutical company MSD (also known as Merck & Co and Merck Sharp & Dohme) has announced it will be committing $10 million (£8 million) to the Global Financing Facility (GFF) in support of the Every Woman Every Child strategy to improve maternal and child health in low and lower middle-income countries worldwide through its MSD for Mothers initiative.

Through the GFF, countries are aiming to make a much greater impact on the lives of their most vulnerable citizens, with the goal of preventing an estimated 3.8 million maternal deaths, 101 million child deaths and 21 million stillbirths by 2030.

Kenneth Frazier, chairman and chief executive officer at MSD, said: “Women are the cornerstone of a healthy and prosperous world. When a woman survives pregnancy and childbirth, her family, community and nation thrive.

“Our partnership with the GFF demonstrates how the private sector can play a unique role in helping to improve maternal and child health worldwide. We look forward to contributing our resources and expertise to the GFF and its partner organisations to work toward the common goal of ending preventable maternal and child deaths.”ADNFCR-2094-ID-801832035-ADNFCR